Alzheimer's disease clinical trials are pivotal in the ongoing battle against dementia. These trials test new treatments and therapies aimed at slowing or halting the progression of Alzheimer's, a degenerative brain disorder that impairs memory and cognitive functions. Researchers recruit participants to evaluate the safety and efficacy of experimental drugs or interventions, often comparing them to placebos or standard treatments. The goal is to discover breakthroughs that can improve quality of life for those affected by Alzheimer's and possibly find a cure. Participation in clinical trials not only offers potential benefits to patients but also advances scientific understanding of the disease. It's crucial for participants to be well-informed about the risks and potential outcomes before deciding to join, contributing to the collective effort in finding effective treatments for Alzheimer's disease.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States